Hannah Hieb, MOTR/L - Medicare Occupational Therapist in Casper, WY

Hannah Hieb, MOTR/L is a medicare enrolled "Occupational Therapist" provider in Casper, Wyoming. Her current practice location is 2020 E 12th St, Casper, Wyoming. You can reach out to her office (for appointments etc.) via phone at (307) 235-5097.

Hannah Hieb is licensed to practice in Wyoming (license number 1438) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1033765821.

Contact Information

Hannah Hieb, MOTR/L
2020 E 12th St,
Casper, WY 82601-4007
(307) 235-5097
(307) 358-9330



Healthcare Provider's Profile

Full NameHannah Hieb
GenderFemale
SpecialityOccupational Therapist
Location2020 E 12th St, Casper, Wyoming
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1033765821
  • Provider Enumeration Date: 08/16/2019
  • Last Update Date: 02/07/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 2961732870
  • Enrollment ID: I20190919000548

Medical Identifiers

Medical identifiers for Hannah Hieb such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1033765821NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225X00000XOccupational Therapist 1438 (Wyoming)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Hannah Hieb allows following entities to bill medicare on her behalf.
Provider NameNorth Platte Physical Therapy Services Inc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1093914111
PECOS PAC ID: 8921080565
Enrollment ID: O20040607000307

News Archive

Patient enrollment complete in Enlivex Phase I/II clinical trial for autoimmune diseases

Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that the recruitment of 13 patients for the Enlivex Phase I/II clinical trial has been completed.

Scientists raise concerns about exposure to hazardous mineral fibers among off-road vehicle users

Preventing injuries may not be the only reason children shouldn't use off-road vehicles (ORVs). In a new study, public health scientists raise concerns that people who use ORVs in many regions of the country may face exposure to hazardous mineral fibers. These include naturally occurring asbestos and erionite - an asbestos-like material that occurs in sedimentary rocks of the western United States.

New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer

A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a cancer-associated molecule called MET is added to treatment with erlotinib, the results of a double-blind Phase-II trial show.

Abbott Biotech Ventures invests in Alvine Pharmaceuticals

Alvine Pharmaceuticals, Inc., a privately held clinical stage biopharmaceutical company focused on developing and commercializing therapeutics for autoimmune/inflammatory diseases, today announced that Abbott Biotech Ventures Inc., has joined Alvine's current investors: Interwest Partners, Panorama Capital, Prospect Venture Partners, Sofinnova Ventures, Black River Asset Management and Flagship Ventures in the company's Series A Extension financing. The terms of the investment were not disclosed.

Researchers study prevalence of SARS-CoV-2 UK variant at University of Texas

Researchers at the University of Texas at Austin and Santa Fe Institute in the US used quantitative polymerase chain reaction (PCR) data from a surveillance testing program on a large university campus to estimate how fast the new variant spreads. The team used the data to provide local situational information on the COVID-19 pandemic.

Read more Medical News

› Verified 8 days ago

Provider NameBig Country Rehabilitation Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1366493264
PECOS PAC ID: 0648253666
Enrollment ID: O20040610001233

News Archive

Patient enrollment complete in Enlivex Phase I/II clinical trial for autoimmune diseases

Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that the recruitment of 13 patients for the Enlivex Phase I/II clinical trial has been completed.

Scientists raise concerns about exposure to hazardous mineral fibers among off-road vehicle users

Preventing injuries may not be the only reason children shouldn't use off-road vehicles (ORVs). In a new study, public health scientists raise concerns that people who use ORVs in many regions of the country may face exposure to hazardous mineral fibers. These include naturally occurring asbestos and erionite - an asbestos-like material that occurs in sedimentary rocks of the western United States.

New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer

A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a cancer-associated molecule called MET is added to treatment with erlotinib, the results of a double-blind Phase-II trial show.

Abbott Biotech Ventures invests in Alvine Pharmaceuticals

Alvine Pharmaceuticals, Inc., a privately held clinical stage biopharmaceutical company focused on developing and commercializing therapeutics for autoimmune/inflammatory diseases, today announced that Abbott Biotech Ventures Inc., has joined Alvine's current investors: Interwest Partners, Panorama Capital, Prospect Venture Partners, Sofinnova Ventures, Black River Asset Management and Flagship Ventures in the company's Series A Extension financing. The terms of the investment were not disclosed.

Researchers study prevalence of SARS-CoV-2 UK variant at University of Texas

Researchers at the University of Texas at Austin and Santa Fe Institute in the US used quantitative polymerase chain reaction (PCR) data from a surveillance testing program on a large university campus to estimate how fast the new variant spreads. The team used the data to provide local situational information on the COVID-19 pandemic.

Read more Medical News

› Verified 8 days ago

Provider NameBear Lodge Rehabilitation Services, Llc
Provider TypePart B Supplier - Physical/occupational Therapy Group In Private Practice
Provider IdentifiersNPI Number: 1558690099
PECOS PAC ID: 7911041199
Enrollment ID: O20100225000900

News Archive

Patient enrollment complete in Enlivex Phase I/II clinical trial for autoimmune diseases

Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that the recruitment of 13 patients for the Enlivex Phase I/II clinical trial has been completed.

Scientists raise concerns about exposure to hazardous mineral fibers among off-road vehicle users

Preventing injuries may not be the only reason children shouldn't use off-road vehicles (ORVs). In a new study, public health scientists raise concerns that people who use ORVs in many regions of the country may face exposure to hazardous mineral fibers. These include naturally occurring asbestos and erionite - an asbestos-like material that occurs in sedimentary rocks of the western United States.

New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer

A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a cancer-associated molecule called MET is added to treatment with erlotinib, the results of a double-blind Phase-II trial show.

Abbott Biotech Ventures invests in Alvine Pharmaceuticals

Alvine Pharmaceuticals, Inc., a privately held clinical stage biopharmaceutical company focused on developing and commercializing therapeutics for autoimmune/inflammatory diseases, today announced that Abbott Biotech Ventures Inc., has joined Alvine's current investors: Interwest Partners, Panorama Capital, Prospect Venture Partners, Sofinnova Ventures, Black River Asset Management and Flagship Ventures in the company's Series A Extension financing. The terms of the investment were not disclosed.

Researchers study prevalence of SARS-CoV-2 UK variant at University of Texas

Researchers at the University of Texas at Austin and Santa Fe Institute in the US used quantitative polymerase chain reaction (PCR) data from a surveillance testing program on a large university campus to estimate how fast the new variant spreads. The team used the data to provide local situational information on the COVID-19 pandemic.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Hannah Hieb is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Hannah Hieb, MOTR/L
2020 E 12th St,
Casper, WY 82601-4007

Ph: (307) 235-5097
Hannah Hieb, MOTR/L
2020 E 12th St,
Casper, WY 82601-4007

Ph: (307) 235-5097

News Archive

Patient enrollment complete in Enlivex Phase I/II clinical trial for autoimmune diseases

Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that the recruitment of 13 patients for the Enlivex Phase I/II clinical trial has been completed.

Scientists raise concerns about exposure to hazardous mineral fibers among off-road vehicle users

Preventing injuries may not be the only reason children shouldn't use off-road vehicles (ORVs). In a new study, public health scientists raise concerns that people who use ORVs in many regions of the country may face exposure to hazardous mineral fibers. These include naturally occurring asbestos and erionite - an asbestos-like material that occurs in sedimentary rocks of the western United States.

New targeted therapy adds benefit to erlotinib in some patients with advanced lung cancer

A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a cancer-associated molecule called MET is added to treatment with erlotinib, the results of a double-blind Phase-II trial show.

Abbott Biotech Ventures invests in Alvine Pharmaceuticals

Alvine Pharmaceuticals, Inc., a privately held clinical stage biopharmaceutical company focused on developing and commercializing therapeutics for autoimmune/inflammatory diseases, today announced that Abbott Biotech Ventures Inc., has joined Alvine's current investors: Interwest Partners, Panorama Capital, Prospect Venture Partners, Sofinnova Ventures, Black River Asset Management and Flagship Ventures in the company's Series A Extension financing. The terms of the investment were not disclosed.

Researchers study prevalence of SARS-CoV-2 UK variant at University of Texas

Researchers at the University of Texas at Austin and Santa Fe Institute in the US used quantitative polymerase chain reaction (PCR) data from a surveillance testing program on a large university campus to estimate how fast the new variant spreads. The team used the data to provide local situational information on the COVID-19 pandemic.

Read more News

› Verified 8 days ago


Occupational Therapist in Casper, WY

Olivia L Donald, OTRL
Occupational Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 2665 E 2nd St, Casper, WY 82609
Phone: 307-337-1740    
Natalie M Jennings,
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 428 S Durbin St Ste 104, Casper, WY 82601
Phone: 307-337-4284    Fax: 307-224-3436
Lauren Hiipakka, OTR
Occupational Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 4270 S Poplar St, Casper, WY 82601
Phone: 307-333-6200    
Mrs. Kelly Ann Reed, OTR/L
Occupational Therapist
Medicare: May Accept Medicare Assignments
Practice Location: 3245 Whitcomb Rd, Casper, WY 82601
Phone: 307-258-8028    
Erika Swirzcki,
Occupational Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 2601 Waterford, Casper, WY 82609
Phone: 307-267-2243    
Janice Finley, OT
Occupational Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 4140 Centennial Hills Blvd Ste B, Casper, WY 82609
Phone: 307-472-8871    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.